KIORA PHARMACEUTICALS INC Reports Q1 Loss of $0.58 Per Share in SEC Filing
Financial Performance: Kiora Pharmaceuticals reported a loss of $0.58 per share for the first quarter.
Regulatory Filing: The company has submitted a filing with the Securities and Exchange Commission (SEC) regarding its financial results.
Trade with 70% Backtested Accuracy
Analyst Views on EYEG
About the author
KIORA PHARMACEUTICALS INC Reports Q1 Loss of $0.58 Per Share in SEC Filing
Financial Performance: Kiora Pharmaceuticals reported a loss of $0.58 per share for the first quarter.
Regulatory Filing: The company has submitted a filing with the Securities and Exchange Commission (SEC) regarding its financial results.
KIORA PHARMACEUTICALS INC TO OFFER 438,471 COMMON STOCK SHARES THROUGH PRIVATE PLACEMENT - SEC FILING
Company Overview: Kiora Pharmaceuticals is involved in the development and commercialization of pharmaceutical products, focusing on innovative therapies.
Stock Information: The company has issued 438,471 shares of common stock in a private placement, indicating a move to raise capital for its operations.
KIORA PHARMACEUTICALS INC Reports Q1 Loss of $0.58 Per Share in SEC Filing
Financial Performance: Kiora Pharmaceuticals reported a loss of $0.58 per share for the first quarter.
Regulatory Filing: The company has submitted a filing with the Securities and Exchange Commission (SEC) regarding its financial results.
KIORA PHARMACEUTICALS INC TO OFFER 438,471 COMMON STOCK SHARES THROUGH PRIVATE PLACEMENT - SEC FILING
Company Overview: Kiora Pharmaceuticals is involved in the development and commercialization of pharmaceutical products, focusing on innovative therapies.
Stock Information: The company has issued 438,471 shares of common stock in a private placement, indicating a move to raise capital for its operations.
